BioClinica expands imaging services in Europe with two new offices

By Zachary Brennan

- Last updated on GMT

Related tags Medical imaging Medicine Clinical trial

BioClinica expands imaging services in Europe with two new offices
BioClinica has opened offices in London and Munich to provide its European clients with expanded clinical trial services including medical imaging, site training and support, and eClinical product lines.

The combined space of 1,400 square meters across the two sites will specifically focus on medical imaging services, including an advanced image analysis center for BioClinica’s network of European radiologists and imaging specialists. 

As far as why this additional space may be necessary, John Hubbard, CEO of BioClinica, told “Imaging endpoints and biomarkers are becoming increasingly important as primary and secondary endpoints for demonstrating efficacy and safety in clinical trials. This is reflected in the current growth of the medical imaging sector at approximately 7-10% annually​.” 

Medical imaging can also provide early insight for the diagnosis, prognosis, and progression of complex diseases, which can help sponsors make decisions on trial enrollment and the advancement of pipeline candidates, Hubbard said, noting this is “especially true in the rapidly growing therapeutic areas of oncology, inflammatory disease, musculoskeletal disease, and neurological disorders​.” 

In addition to the imaging services, BioClinica’s eClinical Solutions business will also operate from these two new offices, Hubbard said. “We are seeing a high level of interest in our clinical technology products, including OnPoint CTMS (clinical trial management system) and Compass (intelligent risk based monitoring), designed to help sponsors run faster, more efficient clinical trials​.” 

David Herron, BioClinica’s President of Medical Imaging, Cardiovascular Safety, and Molecular Markers, added: “Our expansion will provide the resources needed for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us